Phospho-PDGFRB (Y771) Antibody

What is Phospho-PDGFRB (Y771) Antibody and what specifically does it detect?

Phospho-PDGFRB (Y771) antibody is a specialized immunological reagent that recognizes the platelet-derived growth factor receptor beta protein only when phosphorylated at tyrosine residue 771. This site-specific antibody enables researchers to monitor the activation state of PDGFRB by detecting phosphorylation at this particular residue, which has been implicated in specific downstream signaling events . The antibody binds to the phosphorylated tyrosine residue and surrounding amino acid sequences, providing high specificity for this post-translational modification.

What is the biological significance of PDGFRB phosphorylation at Y771?

Phosphorylation at Y771 of PDGFRB serves as a direct binding site for the SH2 domain of the Abl2 protein, a non-receptor tyrosine kinase involved in cytoskeletal regulation. Research has demonstrated that mutation of Y771 to phenylalanine (Y771F) reduces binding to the Abl2 SH2 domain by approximately 90%, indicating this phosphorylation site is critical for PDGFRB-Abl2 interaction . This interaction contributes to downstream signaling pathways that regulate cellular processes such as migration, proliferation, and differentiation. Additionally, Y771 phosphorylation represents a key regulatory node that can be selectively modulated by protein tyrosine phosphatases, enabling precise control of PDGFRB signaling outcomes .

What experimental applications are appropriate for Phospho-PDGFRB (Y771) Antibody?

Phospho-PDGFRB (Y771) antibodies have been validated for multiple research applications:

These applications enable researchers to detect and quantify Y771 phosphorylation in various experimental contexts, from protein lysates to intact cells . The choice of application depends on whether qualitative detection, quantitative measurement, or spatial localization of phosphorylated PDGFRB is required.

How should I optimize Western blot protocols for Phospho-PDGFRB (Y771) Antibody?

For optimal detection of phosphorylated PDGFRB (Y771) by Western blot:

• Include appropriate stimulation controls: Treat cells with PDGF-BB (100 ng/mL for 10 minutes) to induce receptor phosphorylation .

• Preserve phosphorylation status:

  • Use phosphatase inhibitors (sodium orthovanadate, sodium fluoride) in lysis buffers

  • Maintain samples at 4°C during processing

  • Process samples quickly to minimize dephosphorylation

• Recommended protocol parameters:

  • Use reducing conditions with Immunoblot Buffer Group 1

  • Transfer to PVDF membrane for optimal retention of phosphoproteins

  • Primary antibody dilution: 1:1000 (may require optimization)

  • Blocking: 5% BSA in TBST (preferred over milk for phospho-antibodies)

  • Include both stimulated and unstimulated controls on the same blot

The expected molecular weight for phospho-PDGFRB is approximately 123 kDa, though the apparent size may be higher (~190 kDa) due to glycosylation and other post-translational modifications .

How does PDGF stimulation affect Y771 phosphorylation compared to other PDGFRB phosphorylation sites?

PDGFRB contains multiple tyrosine phosphorylation sites that become phosphorylated upon ligand binding, each with distinct kinetics and functional outcomes:

Studies have demonstrated that Y771 phosphorylation is particularly critical for Abl2 recruitment, as Y771F mutation reduces Abl2 binding by 90%, while other tyrosine mutations have minimal effects . Meanwhile, the Y1021 site shows the largest increase in phosphorylation following stimulation and is associated with migratory hyperresponsiveness to PDGF . This site-selective phosphorylation pattern enables precise control of downstream pathway activation.

What are appropriate positive and negative controls when using Phospho-PDGFRB (Y771) Antibody?

To ensure experimental validity when using Phospho-PDGFRB (Y771) antibodies:

Positive Controls:

• NIH/3T3 cells treated with PDGF-BB (100 ng/mL, 10 minutes)

• Human foreskin fibroblasts treated with PDGF-BB (100 ng/mL, 10 minutes)

• In vitro autophosphorylated recombinant PDGFRB catalytic domain

Negative Controls:

• Unstimulated cells expressing PDGFRB

• Cells treated with PDGFR kinase inhibitors prior to PDGF stimulation

• Y771F PDGFRB mutant-expressing cells (shows ~90% reduction in signal)

• Dephosphorylated PDGFRB (e.g., lambda phosphatase-treated)

• Phosphopeptide competition assay using the immunizing phosphopeptide

These controls ensure antibody specificity and help validate phosphorylation-dependent signals in experimental systems.

How does the Phospho-PDGFRB (Y771) site regulate interaction with Abl2 and subsequent signaling events?

The interaction between phosphorylated Y771 of PDGFRB and the Abl2 SH2 domain represents a critical regulatory mechanism in PDGF signaling:

• Direct Binding Mechanism: Purified studies demonstrate that the Abl2 SH2 domain binds directly to phosphorylated Y771 with submicromolar affinity (Kd = 0.26 ± 0.07 μM) . This interaction is abolished by the R198K mutation in the Abl2 SH2 domain, confirming a canonical phosphotyrosine-SH2 binding mechanism.

• Abl2 Activation Pathway: Following binding to phospho-Y771, PDGFRB phosphorylates Abl2 at multiple sites:

  • Y116, Y139, Y161 in the SH3 domain

  • Y272 in the SH2-kinase linker (critical site)

  • Y299, Y303, Y310, Y439 in the kinase domain

• Regulatory Consequences: Phosphorylation at these sites, particularly those at the SH3/SH2-kinase linker interface (Y116, Y161, Y272, Y310), disrupts Abl2's autoinhibitory conformation, resulting in kinase activation . This represents a direct mechanism by which PDGFRB controls Abl2 activity through initial binding at the phospho-Y771 site.

This molecular understanding provides insight into how site-specific phosphorylation events propagate signals through protein-protein interactions and subsequent phosphorylation cascades.

What are the methodological approaches for studying site-selective regulation of PDGFRB phosphorylation?

Investigating site-selective regulation of PDGFRB phosphorylation requires sophisticated methodological approaches:

• Phospho-specific antibodies in multi-plex analysis:

  • Use multiple phospho-specific antibodies (Y751, Y771, Y1021, etc.) to simultaneously monitor site-selective phosphorylation patterns

  • Can be combined with phosphatase inhibitor treatments to identify site-selective dephosphorylation

• Mutagenesis approaches:

  • Single Y→F mutations at specific sites (e.g., Y771F, Y751F)

  • Phosphomimetic mutations (Y→E) to simulate constitutive phosphorylation

  • Domain swap experiments to identify regulatory regions

• Proximity Ligation Assay (PLA):

  • Enables visualization of individual phosphorylated PDGFRB molecules in situ

  • Requires antibody pairs: one against phospho-Y771 and another against total PDGFRB

  • Each red dot in images represents a single phosphorylated protein molecule

  • Allows quantitative spatial analysis using software like BlobFinder

• Mass spectrometry-based phosphoproteomics:

  • Enables unbiased identification and quantification of multiple phosphorylation sites

  • Can reveal temporal dynamics of site-specific phosphorylation

  • Requires careful sample preparation to preserve phosphorylation status

These complementary approaches provide comprehensive insights into the complex regulation of PDGFRB phosphorylation at specific tyrosine residues.

How do protein tyrosine phosphatases selectively modulate PDGFRB Y771 phosphorylation?

Protein tyrosine phosphatases (PTPs) exhibit remarkable site selectivity in regulating PDGFRB phosphorylation:

• TC-PTP (T-cell Protein Tyrosine Phosphatase):

  • Newly identified negative regulator of PDGFRB signaling

  • Demonstrates site-selective dephosphorylation patterns

  • Depletion affects some phosphorylation sites more than others

• PTP-1B:

  • Regulates PDGFRB phosphorylation with a site distribution different from TC-PTP

  • Knockout cells show increased PDGFRB tyrosine phosphorylation

  • Does not enhance PDGF-induced migration, unlike TC-PTP depletion

• PTPε:

  • Unlike PTP-1B, knockout of PTPε does not increase PDGFRB phosphorylation

  • Demonstrates phosphatase specificity toward particular RTKs

This site-selective regulation by PTPs creates an additional layer of control over PDGFRB signaling, allowing for fine-tuning of downstream pathway activation. The mechanism likely involves a combination of phosphatase catalytic site architecture, substrate recognition determinants, and spatial organization within the cell.

How can Phospho-PDGFRB (Y771) Antibody be used in investigations of receptor crosstalk?

Investigating receptor crosstalk with Phospho-PDGFRB (Y771) antibodies requires strategic experimental designs:

• Co-stimulation experiments:

  • Treat cells with PDGF-BB plus other growth factors (EGF, FGF, IGF)

  • Monitor Y771 phosphorylation status using the phospho-specific antibody

  • Assess changes in phosphorylation kinetics or magnitude

• Receptor inhibition studies:

  • Selectively inhibit one receptor tyrosine kinase while activating another

  • Use small molecule inhibitors or neutralizing antibodies

  • Quantify effects on Y771 phosphorylation by Western blot or ELISA

• Proximity Ligation Assay applications:

  • Combine Phospho-PDGFRB (Y771) antibody with antibodies against other RTKs

  • Visualize potential physical associations between phosphorylated PDGFRB and other receptors

  • Quantify spatial relationships using image analysis software

• Phosphatase manipulation:

  • Overexpress or knock down specific phosphatases (TC-PTP, PTP-1B)

  • Assess changes in Y771 phosphorylation patterns during co-stimulation

  • Identify phosphatases that may coordinate signals between receptor systems

These approaches can reveal how PDGFRB phosphorylation at Y771 is influenced by or influences other receptor signaling systems, providing insight into complex cellular communication networks.

What are the optimal storage and handling conditions for Phospho-PDGFRB (Y771) Antibody?

To maintain antibody performance and extend shelf life:

Most commercially available Phospho-PDGFRB (Y771) antibodies are shipped in liquid form and should be handled with care to maintain their phospho-specificity . Repeated freeze-thaw cycles should be strictly avoided as they can significantly compromise antibody performance and specificity.

How can I troubleshoot weak or non-specific signals when using Phospho-PDGFRB (Y771) Antibody?

Common issues and solutions when working with Phospho-PDGFRB (Y771) antibodies:

• Weak or absent signal:

  • Verify PDGF stimulation conditions (100 ng/mL for 10 minutes is standard)

  • Ensure phosphatase inhibitors are fresh and active in lysis buffers

  • Try increasing antibody concentration (1:500 instead of 1:1000)

  • Use enhanced chemiluminescence (ECL) substrate with higher sensitivity

  • Confirm sample preparation preserves phosphorylation (rapid processing, cold temperatures)

• High background or non-specific bands:

  • Use 5% BSA for blocking instead of milk (phospho-epitopes bind to milk proteins)

  • Increase washing time and volume (5 × 5 minutes with TBST)

  • Optimize primary antibody dilution (try more dilute solutions)

  • Ensure secondary antibody is compatible and highly specific

  • Consider using a more specific monoclonal antibody if using polyclonal

• Inconsistent results:

  • Standardize cell stimulation protocols precisely (timing, concentration, temperature)

  • Use consistent cell densities and passage numbers

  • Prepare fresh lysates for each experiment rather than freeze-thawing samples

  • Include internal loading controls and phosphorylation controls

These troubleshooting approaches can help optimize experimental conditions for reliable detection of phosphorylated PDGFRB (Y771).

What are emerging applications of Phospho-PDGFRB (Y771) Antibody in cancer research?

The role of PDGFRB signaling in cancer progression makes Phospho-PDGFRB (Y771) antibodies valuable tools in oncology research:

• Biomarker development:

  • Monitoring Y771 phosphorylation status in patient samples

  • Correlation with response to receptor tyrosine kinase inhibitors

  • Potential predictive marker for therapy selection

• Therapeutic target validation:

  • Assessing effects of novel compounds on site-specific phosphorylation

  • Understanding resistance mechanisms to existing therapies

  • Identifying compensatory phosphorylation patterns

• Pathway crosstalk in tumor microenvironment:

  • Examining interactions between tumor cells and stromal components

  • Investigating paracrine signaling effects on PDGFRB phosphorylation

  • Understanding the role of Y771 phosphorylation in tumor-stroma interactions

As our understanding of site-specific phosphorylation in cancer signaling evolves, Phospho-PDGFRB (Y771) antibodies will continue to be important tools for basic and translational cancer research.

How can computational approaches complement experimental use of Phospho-PDGFRB (Y771) Antibody?

Integration of computational methods with phospho-specific antibody data provides powerful insights:

• Phosphorylation site conservation analysis:

  • Evaluating evolutionary conservation of Y771 across species

  • Predicting functional importance based on conservation patterns

  • Identifying potentially similar regulatory mechanisms in related receptors

• Molecular dynamics simulations:

  • Modeling structural changes induced by Y771 phosphorylation

  • Predicting effects on protein-protein interaction surfaces

  • Simulating conformational changes that expose or mask other phosphorylation sites

• Systems biology approaches:

  • Integrating phospho-specific antibody data into signaling network models

  • Predicting cellular responses to perturbations in Y771 phosphorylation

  • Identifying potential feedback loops and cross-regulation mechanisms

• Machine learning applications:

  • Training algorithms to recognize patterns in phosphorylation data across multiple sites

  • Predicting cellular phenotypes based on site-specific phosphorylation profiles

  • Identifying novel regulatory relationships within signaling networks